Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study
Crossref DOI link: https://doi.org/10.1007/s10067-017-3757-8
Published Online: 2017-07-30
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gaubitz, Markus
Göttl, Karl-Heinz
Behmer, Olaf
Lippe, Ralph
Meng, Thomas
Löschmann, Peter-Andreas
Funding for this research was provided by:
Pfizer (Germany)
License valid from 2017-07-30
